The German publication Going Public featured a Q&A with AMR Action Fund's Chief Investment Officer, Martin Heidecker, PhD, in its February issue.
The conversation covered a range of topics, including the AMR Action Fund’s investment focus, the state of antimicrobial innovation across Europe, and the need for market-based policy reforms to stimulate private investment.
The full interview, in German, can be found here.
